Retention and Overdose Risk among Patients Receiving Substance Use Disorder Treatment, Mental Health Care and Peer Recovery Support: A Longitudinal Analysis
Ju Nyeong Park(John Brown University), Oluwaseun Falade‐Nwulia(Johns Hopkins University), Gregory M. Lucas(Johns Hopkins University), Jeffrey Hsu(Johns Hopkins University), Tracy Agee(Johns Hopkins University), S. Thomas McCormick(Johns Hopkins University), Nicholas Schweizer(Johns Hopkins University), Marisa Felsher(Merck & Co., Inc., Rahway, NJ, USA (United States)), Karina Collins(Johns Hopkins University)
Cited by 9
Related Papers
Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection
|Clinical Infectious Diseases|2018|728
Oral Direct-Acting Agent Therapy for Hepatitis C Virus Infection
|Annals of Internal Medicine|2017|694
End-Stage Renal Disease Among HIV-Infected Adults in North America
|Clinical Infectious Diseases|2014|172